KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abbott Laboratories (ABT) Net Margin (2016 - 2025)

Historic Net Margin for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to 14.46%.

  • Abbott Laboratories' Net Margin fell 10200.0% to 14.46% in Q3 2025 from the same period last year, while for Sep 2025 it was 31.88%, marking a year-over-year increase of 178900.0%. This contributed to the annual value of 31.95% for FY2024, which is 176800.0% up from last year.
  • Per Abbott Laboratories' latest filing, its Net Margin stood at 14.46% for Q3 2025, which was down 10200.0% from 15.97% recorded in Q2 2025.
  • In the past 5 years, Abbott Laboratories' Net Margin ranged from a high of 84.1% in Q4 2024 and a low of 10.24% during Q4 2022
  • In the last 5 years, Abbott Laboratories' Net Margin had a median value of 14.46% in 2025 and averaged 18.54%.
  • As far as peak fluctuations go, Abbott Laboratories' Net Margin plummeted by -70400bps in 2022, and later skyrocketed by 685300bps in 2024.
  • Over the past 5 years, Abbott Laboratories' Net Margin (Quarter) stood at 17.27% in 2021, then tumbled by -41bps to 10.24% in 2022, then soared by 52bps to 15.56% in 2023, then surged by 440bps to 84.1% in 2024, then crashed by -83bps to 14.46% in 2025.
  • Its Net Margin stands at 14.46% for Q3 2025, versus 15.97% for Q2 2025 and 12.79% for Q1 2025.